Data Sheet

MSDS

Patritumab [CAS 1262787-83-6]

CAS No:	1262787-83-6
Applications:	Cancer-Kinase/protease
MW:	N/A
Formula:	N/A
SMILES:	[Patritumab]
Purity:	98.94
Description:	Patritumab (Human Anti-ERBB3 Recombinant Antibody) is a neutralizing monoclonal antibody to ERBB3. Patritumab shows a synergy with Cetuximab (HY-P9905), potently inhibits the phosphorylation of EGFR, HER2, HER3, ERK, and AKT. Patritumab also induces cell apoptosis and suppresses the growth of pancreatic, non-small cell lung cancer, and colorectal cancer xenograft tumors[1].
Shipping Conditions:	Ship on dry ice
Usage:	Research Use Only